Test Price
2,800 AED✅ Home Collection Available
NEXN Gene Dilated Cardiomyopathy Type 1CC Genetic Test in UAE | AED 2800 | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM).
- Clinical Guidance: Post-Test Telephonic Interpretation by DHA-Licensed Clinical Geneticist.
- Insurance & Billing: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The NEXN Gene Dilated Cardiomyopathy Type 1CC Genetic Test uses Next-Generation Sequencing (NGS) to detect pathogenic variants in the NEXN gene, confirming hereditary dilated cardiomyopathy type 1CC. This definitive molecular diagnosis enables risk stratification for at‑risk family members, guides implantable cardioverter‑defibrillator (ICD) decisions, and facilitates cascade screening.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% analytical sensitivity & specificity for NEXN mutations via NGS | Sanger sequencing of selected exons – may miss deep intronic variants; 95–98% sensitivity |
| Method | Illumina® Next-Generation Sequencing with full bioinformatics analysis & MLPA confirmation | Targeted gene panel without CNV detection; no comprehensive deletion/duplication analysis |
| Turnaround | 3–4 Weeks from sample receipt | 4–6 Weeks |
Physician Insight & Safety Protocols
As a Consultant Medical Geneticist, I emphasize that a definitive molecular diagnosis of NEXN-related cardiomyopathy enables precise family risk assessment and early intervention. This test, combined with clinical correlation, can prevent sudden cardiac events in at-risk relatives. Always consult your genetic counselor and cardiologist before making medical decisions.
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory: Do Not Discontinue Prescribed Medication
Do not alter or stop any current medication without explicit consultation with your treating physician. The results of this genetic test are meant to inform, not replace, medical supervision.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Not validated for prenatal diagnosis or asymptomatic minors without parental consent, in compliance with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability and applicable ethical guidelines.
- Exclusion: Not recommended for individuals who received a blood transfusion within the past 4 weeks due to potential donor DNA interference.
- Emergency Red Flag: Sudden chest pain, syncope (fainting), palpitations with dizziness, or severe breathlessness — seek immediate medical attention, especially with a family history of sudden cardiac death.
- Emergency Red Flag: New‑onset heart failure symptoms (leg swelling, profound fatigue) should prompt urgent cardiological evaluation.
Patient FAQ & Clinical Guidance
1. What is the NEXN Gene Dilated Cardiomyopathy Type 1CC test?
It is a DNA sequencing analysis targeting the NEXN gene to confirm hereditary dilated cardiomyopathy type 1CC. This test identifies pathogenic variants responsible for the disease, enabling early intervention and family screening.
2. How should I prepare for the NEXN genetic test?
Provide a complete family history and attend a genetic counseling session to chart your pedigree accurately. A three‑generation pedigree is essential for accurate variant interpretation. No special dietary or medication restrictions are needed.
3. Is the NEXN genetic test covered by UAE health insurance?
Many UAE insurers cover genetic testing for cardiomyopathies when medically necessary. To verify direct billing and obtain pre‑authorization, please contact us via WhatsApp at +971 54 548 8731. A referral from a DHA‑licensed cardiologist may be required.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and handled under strict confidentiality protocols. Your results are shared only with you and your designated healthcare provider.
Clinical & Logistical Metadata
| Test Name | NEXN Gene Dilated Cardiomyopathy Type 1CC Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3–5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) with bioinformatics analysis and MLPA confirmation |
| ICD-10-CM Code | I42.0 |
| LOINC Code | 92742-5 |
| DHA Facility License & Laboratory Address | 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians